Title: Cellink BIO X Advanced Multi-Material 3D Bioprinting System for Cancer Biology and Organoid Research

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition for a high-precision 3D bioprinting platform capable of reproducibly fabricating multicellular tissue constructs using a variety of bioinks and biomaterials. The system must integrate with existing cell culture, microscopy, and downstream molecular analysis workflows while enabling standardized production of physiologically relevant in vitro models. • The contract is for the Cellink BIO X Advanced Multi-Material 3D Bioprinting System for Cancer Biology and Organoid Research. • The system must be capable of reproducibly fabricating multicellular tissue constructs using a variety of bioinks and biomaterials. • The system must integrate with existing cell culture, microscopy, and downstream molecular analysis workflows. • The system must enable standardized production of physiologically relevant in vitro models.